GetTopicDetailResponse(id=88b48904327, topicName=血小板生成素受體激動劑, introduction=血小板生成素受體激動劑, content=null, image=null, comments=4, allHits=1488, url=https://h5.medsci.cn/topic?id=89043, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=100314, tagList=[TagDto(tagId=100314, tagName=血小板生成素受體激動劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1368766, encodeId=bb221368e6618, content=<a href='/topic/show?id=88b48904327' target=_blank style='color:#2F92EE;'>#血小板生成素受體激動劑#</a>, objectTitle=Blood：血小板生成素受體激動劑在ITP老年患者中的實際應用情況, objectType=article, longId=216350, objectId=6bdb21635063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bdb21635063, replyNumber=0, likeNumber=96, createdTime=2021-08-28, rootId=0, userName=whmdzju, userId=3860283, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bdb21635063, moduleTitle=Blood：血小板生成素受體激動劑在ITP老年患者中的實際應用情況, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6bdb21635063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368765, encodeId=20121368e65c6, content=<a href='/topic/show?id=88b48904327' target=_blank style='color:#2F92EE;'>#血小板生成素受體激動劑#</a>, objectTitle=Shionogi宣布在英國推出血小板生成素受體激動劑Mulpleo（lusutrombopag），用于接受侵入性治療的慢性肝病成年患者的嚴重血小板減少癥, objectType=article, longId=189673, objectId=433d1896e3eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=433d1896e3eb, replyNumber=0, likeNumber=118, createdTime=2020-03-12, rootId=0, userName=柳葉一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=433d1896e3eb, moduleTitle=Shionogi宣布在英國推出血小板生成素受體激動劑Mulpleo（lusutrombopag），用于接受侵入性治療的慢性肝病成年患者的嚴重血小板減少癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=433d1896e3eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368764, encodeId=60db1368e64de, content=<a href='/topic/show?id=88b48904327' target=_blank style='color:#2F92EE;'>#血小板生成素受體激動劑#</a>, objectTitle=NICE推薦將血小板生成素受體激動劑Doptelet用于肝病手術前使用, objectType=article, longId=189454, objectId=0976189454ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0976189454ff, replyNumber=0, likeNumber=86, createdTime=2020-03-07, rootId=0, userName=whmdzju, userId=3860283, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0976189454ff, moduleTitle=NICE推薦將血小板生成素受體激動劑Doptelet用于肝病手術前使用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0976189454ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368763, encodeId=c2281368e63f6, content=<a href='/topic/show?id=88b48904327' target=_blank style='color:#2F92EE;'>#血小板生成素受體激動劑#</a>, objectTitle=兩個新一代促血小板生成素受體激動劑獲準, objectType=article, longId=147458, objectId=eeb414e4583d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eeb414e4583d, replyNumber=0, likeNumber=108, createdTime=2018-08-27, rootId=0, userName=whmdzju, userId=3860283, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eeb414e4583d, moduleTitle=兩個新一代促血小板生成素受體激動劑獲準, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=eeb414e4583d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
